Cite

HARVARD Citation

    Mease, P. et al. (2023). Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE. Rheumatology. pp. 617-628. [Online]. 
  
Back to record